Giant Biogene Holding Co Ltd
HKEX:2367
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
34.1B HKD |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
211.8B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
119B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
35.9B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
39.5B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.6B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
924.4B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Giant Biogene Holding Co Ltd
Glance View
In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Giant Biogene Holding Co Ltd is 37%, which is below its 3-year median of 38.8%.
Over the last 2 years, Giant Biogene Holding Co Ltd’s Net Margin has decreased from 41.2% to 37%. During this period, it reached a low of 37% on Jul 30, 2025 and a high of 41.2% on Dec 1, 2023.